Bufaramine

Bufaramine

dexchlorpheniramine

Manufacturer:

Bufa Aneka
Concise Prescribing Info
Contents
Dexchlorpheniramine maleate
Indications/Uses
Symptomatic treatment of allergic conditions including urticaria, angioedema, rhinitis, conjunctivitis.
Dosage/Direction for Use
Adult & childn ≥12 yr 1 cap 3-4 times daily. Max: 12 mg daily. Childn 6-12 yr Max: 6 mg daily in 3-4 divided doses. Childn 2-6 yr Max: 3 mg daily in 3-4 divided doses.
Administration
Should be taken with food.
Contraindications
Hypersensitivity. Newborn babies, patients under MAOIs treatment.
Special Precautions
Close-angle glaucoma, urinary retention, prostate hyperplasia, pyloroduodenal obstructions, kidney disorders. May impair the ability to drive the vehicle or operate the machinery. Lactation.
Adverse Reactions
Drowsiness, CV, hematology, neurological, GIT, GUT, resp tract reactions. Skin redness, dry mouth.
Drug Interactions
MAOI may prolong & enhance antihistamine effects which can lead to severe hypotension. Use w/ alcohol, TCAs, barbiturate or other antidepressants may enhance sedative effect of dexchlorpheniramine maleate.
ATC Classification
R06AB02 - dexchlorpheniramine ; Belongs to the class of substituted alkylamines used as systemic antihistamines.
Presentation/Packing
Form
Bufaramine cap 2 mg
Packing/Price
10 × 10's (Rp92,169/boks)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in